Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Degasperi · SciRah

Researcher profile · Semantic Scholar

E. Degasperi

Share profile

E. Degasperi — researcher profile on SciRah

h-index: 27
Works: 230
Citations: 2,416

Most-cited papers

Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B
B. Testoni, C. Scholtès, Marie-Laure Plissonnier, Alexia Paturel +10 more
2023Gut66 citations Open access
Semantic Scholar
Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022
P. Lampertico, E. Degasperi, L. Sandmann, H. Wedemeyer
2023JHEP Reports41 citations Open access
Semantic Scholar
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis.
E. Degasperi, M. P. Anolli, M. Jachs, T. Reiberger +51 more
2025Journal of Hepatology40 citations Open access
Semantic Scholar
A 3-Year Course Of Bulevirtide Monotherapy May Cure Hdv Infection In Cirrhotics.
M. P. Anolli, E. Degasperi, L. Allweiss, A. Sangiovanni +7 more
2023Journal of Hepatology31 citations
Semantic Scholar
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis—A real-world case series
C. Dietz-Fricke, E. Degasperi, M. Jachs, B. Maasoumy +15 more
2024Hepatology29 citations Open access
Semantic Scholar
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B.
I. Montali, Camilla Ceccatelli Berti, Marco Morselli, Greta Acerbi +23 more
2023Journal of Hepatology27 citations Open access
Semantic Scholar
Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection
L. Sandmann, E. Degasperi, K. Port, S. Aleman +8 more
2024Alimentary Pharmacology and Therapeutics26 citations
Semantic Scholar
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B
Andrea Vecchi, M. Rossi, Camilla Tiezzi, P. Fisicaro +26 more
2024Gut24 citations Open access
Semantic Scholar
Bulevirtide‐based treatment strategies for chronic hepatitis delta: A review
E. Degasperi, M. P. Anolli, P. Lampertico
2023Journal of Viral Hepatitis22 citations Open access
Semantic Scholar
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and Delta cohort.
L. Kondili, G. Brancaccio, M. Tosti, B. Coco +57 more
2024International Journal of Infectious Diseases14 citations Open access
Semantic Scholar
Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in patients following DAA failure
Christiana Graf, R. D'Ambrosio, E. Degasperi, S. Paolucci +11 more
2024JHEP Reports14 citations Open access
Semantic Scholar
Hepatitis D Virus Infection: Pathophysiology, Epidemiology and Treatment. Report From the Third Delta Cure Meeting 2024
E. Degasperi, L. Sandmann, H. Wedemeyer, P. Lampertico
2025Liver international (Print)13 citations Open access
Semantic Scholar
Quantification of serum HDV RNA by Robogene 2.0 in HDV patients is significantly influenced by the extraction methods
M. P. Anolli, S. Uceda Renteria, E. Degasperi, M. Borghi +6 more
2024Liver international (Print)13 citations Open access
Semantic Scholar
Comparing methods for plasma HDV RNA quantification in bulevirtide-treated and untreated patients with HDV
M. P. Anolli, S. Uceda Renteria, E. Degasperi, F. Facchetti +7 more
2024JHEP Reports12 citations Open access
Semantic Scholar
Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis delta.
E. Degasperi, C. Scholtès, B. Testoni, S. Uceda Renteria +17 more
2024Journal of Hepatology11 citations
Semantic Scholar
Non-invasive assessment of portal hypertension in patients with primary biliary cholangitis is affected by severity of cholestasis.
V. Calvaruso, C. Celsa, L. Cristoferi, M. Scaravaglio +48 more
2024Clinical Gastroenterology and Hepatology11 citations Open access
Semantic Scholar
Development and Validation of a PIVKA‐II‐Based Model for HCC Risk Stratification in Patients With HCV‐Related Cirrhosis Successfully Treated With DAA
G. Caviglia, P. Fariselli, R. D'Ambrosio, P. Colombatto +14 more
2024Alimentary Pharmacology and Therapeutics9 citations Open access
Semantic Scholar
Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populations
Louis M. Shekhtman, S. Cotler, E. Degasperi, M. P. Anolli +8 more
2023JHEP Reports9 citations Open access
Semantic Scholar
Rapid whole-blood immune profiling reveals heterogeneous HBV-specific T cell response patterns independent of clinical disease phases.
N. Le Bert, A. Koffas, Rajneesh Kumar, F. Facchetti +14 more
2025Journal of Hepatology8 citations Open access
Semantic Scholar
Sodium taurocholate cotransporting polypeptide (NTCP) polymorphisms may influence HDV RNA load and early response to bulevirtide.
Pierluigi Toniutto, E. Falleti, Sara Cmet, Annarosa Cussigh +8 more
2024Journal of Hepatology7 citations
Semantic Scholar
Bulevirtide monotherapy prevents liver decompensation and reduces mortality in patients with HDV-related cirrhosis: a case control study with propensity score weighted analysis
E. Degasperi, A. De Silvestri, M. Anolli, D. Sambarino +43 more
2024Digestive and Liver Disease7 citations
Semantic Scholar
Virological and clinical outcomes of patients with HDV-related compensated cirrhosis treated with Bulevirtide monotherapy: the retrospective multicenter European study (Save-D)
E. Degasperi, M. P. Anolli, V. de Lédinghen, S. Metivier +36 more
2023Journal of Hepatology6 citations Open access
Semantic Scholar
HDV RNA and liver disease progression: What do we know?
A. Stockdale, E. Degasperi
2023Hepatology6 citations Open access
Semantic Scholar
Extension of Bulevirtide monotherapy to 72 weeks in HDV patients with compensated cirrhosis: Efficacy and safety from the italian multicenter study (HEP4Di)
M. P. Anolli, E. Degasperi, G. D'Offizi, M. Brunetto +14 more
2023Digestive and Liver Disease6 citations
Semantic Scholar
Bulevirtide for patients with chronic Hepatitis D (CHD) in Italy: a multicenter prospective nationwide real-life study (D-Shield)
M. P. Anolli, E. Degasperi, G. D'Offizi, A. Rianda +38 more
2025Digestive and Liver Disease5 citations
Semantic Scholar
Carriage of the Laboratory of Genetics and Physiology Protein 2 Q425R Variant Reduces Liver Disease Severity in European Patients With Chronic Hepatitis Delta.
Sara Cmet, E. Degasperi, Annarosa Cussigh, E. Fontanini +13 more
2026Alimentary Pharmacology and Therapeutics4 citations Open access
Semantic Scholar
Dynamics of HBV biomarkers during nucleos(t)ide analog treatment: A 14-year study
F. van Bömmel, E. Degasperi, A. van Bömmel, F. Facchetti +8 more
2025Hepatology Communications4 citations Open access
Semantic Scholar
HBsAg Isoforms as Innovative Biomarkers in Predicting Virological Response to Bulevirtide in Patients With Chronic Hepatitis D
S. D'Anna, R. Salpini, E. Degasperi, L. Piermatteo +8 more
2025Liver international (Print)4 citations
Semantic Scholar
WED-291 Long risk of decompensation and HCC in patients with HDV- related compensated cirrhosis treated with Bulevirtide monotherapy for up to 144 weeks: the retrospective multicenter european study (Save-D)
E. Degasperi, M. P. Anolli, Liana Gheorghe, Mirela Chitul +57 more
2025Journal of Hepatology4 citations
Semantic Scholar
Long‐term endoscopic surveillance in HBV compensated cirrhotic patients treated with Tenofovir or Entecavir for 11 years
E. Farina, A. Loglio, G. Tosetti, E. Degasperi +11 more
2023Alimentary Pharmacology and Therapeutics4 citations
Semantic Scholar
AISF-SIMIT practice guidance on treatment of hepatitis d virus (HDV): A 2025 update.
E. Degasperi, M. Pisaturo, A. Aghemo, M. Andreoni +16 more
2026Digestive and Liver Disease3 citations Open access
Semantic Scholar
WED-285-YI Real-world evidence shows comparable Bulevirtide effectiveness in hepatitis D patients with and without cirrhosis: results from the prospective nationwide D-Shield multicenter study
M. P. Anolli, E. Degasperi, G. D'Offizi, A. Rianda +41 more
2025Journal of Hepatology3 citations
Semantic Scholar
TOP-265 Virological outcomes in patients with HDV-related compensated cirrhosis treated with Bulevirtide monotherapy for 144 weeks: a subanalysis of the retrospective multicenter european study (Save-D)
E. Degasperi, M. P. Anolli, S. Monico, M. Jachs +12 more
2025Journal of Hepatology3 citations
Semantic Scholar
Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real‐World Database
A. Loglio, I. Gardini, M. Conforti, M. Bartoli +46 more
2025Liver international (Print)3 citations Open access
Semantic Scholar
OS-120 Bulevirtide monotherapy prevents liver decompensation and reduces mortality in patients with HDV-related cirrhosis: a case control study with propensity score weighted analysis
E. Degasperi, A. De Silvestri, M. P. Anolli, D. Sambarino +42 more
2024Journal of Hepatology3 citations
Semantic Scholar
Off-label Bulevirtide monotherapy for chronic hepatitis D virus infection in patients with decompensated liver disease
C. Dietz-Fricke, E. Degasperi, P. Lampertico, M. Jachs +16 more
2023Journal of Hepatology3 citations
Semantic Scholar
Transcriptional and functional HBV-specific CD8 T cell changes from disease to functional cure in HBeAg-negative chronic hepatitis B
M. Rossi, A. Vecchi, Camilla Tiezzi, F. Guerrieri +19 more
2025JHEP Reports2 citations Open access
Semantic Scholar
THU-272 Appraising improvement in prediction of clinical outcomes based on different response criteria and liver stiffness measurements in patients with primary biliary cholangitis treated with second-line therapies
A. De Vincentis, F. Terracciani, Daphne D'Amato, L. Cristoferi +96 more
2025Journal of Hepatology2 citations
Semantic Scholar
Virological and clinical outcomes of patients with HDV-related compensated cirrhosis treated with Bulevirtide monotherapy for 96 weeks: a retrospective multicenter european study (SAVE-D)
M. Anolli, E. Degasperi, M. Jachs, T. Reiberger +45 more
2024Digestive and Liver Disease2 citations
Semantic Scholar
Baseline predictors of virological and biochemical responses in HDV compensated cirrhotic patients treated with Bulevirtide monotherapy (HEP4Di study)
E. Degasperi, M. Anolli, G. D'Offizi, M. Brunetto +14 more
2024Digestive and Liver Disease2 citations
Semantic Scholar
Advances in hepatitis delta research: emerging insights and future directions
E. Degasperi, M. P. Anolli, P. Lampertico
2024Sexually Transmitted Infections2 citations Open access
Semantic Scholar
Improvement of clinical parameters in HDV patients with advanced compensated cirrhosis treated with Bulevirtide monotherapy for 48 weeks
E. Degasperi, M. Anolli, S. Uceda Renteria, D. Sambarino +9 more
2023Digestive and Liver Disease2 citations
Semantic Scholar
Impact of hepatocellular carcinoma on the risk of liver decompensation: A comparative analysis of patients with and without HCC
A. Martini, M. Iavarone, R. D'Ambrosio, Anna Barone +17 more
2026JHEP Reports1 citations Open access
Semantic Scholar
WED-306 The kinetic of HBsAg isoforms predicts response to BLV and pegylated interferon alfa2a in patients with chronic hepatitis delta
M. Pfefferkorn, H. Rodemerk, E. Degasperi, J. Seltmann +11 more
2025Journal of Hepatology1 citations
Semantic Scholar
SAT-244 Impact of HDV RNA levels on the risk of liver-related outcomes in patients with CHD: a european multicenter validation cohort study
Adriana Palom, E. Degasperi, B. Coco, A. Loglio +14 more
2025Journal of Hepatology1 citations
Semantic Scholar
Hepatitis delta virus (hdv) replication through hbv integrants in hcc recurrence after liver transplantation
L. Di Marco, N. de Maria, A. Pivetti, A. Colecchia +15 more
2025Digestive and Liver Disease1 citations
Semantic Scholar
Hepatitis B Immunoglobulins Withdrawal in Hepatitis B Virus Mono‐Infected Liver Transplant Recipients: An Italian Multicentre Prospective Study
R. Viganò, A. Loglio, C. Dibenedetto, Paola Carrai +20 more
2025Alimentary Pharmacology and Therapeutics1 citations Open access
Semantic Scholar
Characterization of transcriptional and functional CD8 T cell heterogeneity to design individualized correction strategies for chronic HBV infection
M. Rossi, A. Vecchi, F. Guerrieri, C. Tiezzi +12 more
2025Digestive and Liver Disease1 citations
Semantic Scholar
WED-399-YI The composition of HBsAg along with HDV-RNA predicts virological response in chronic hepatitis delta patients treated with bulevirtide for 48 weeks
S. D'Anna, R. Salpini, E. Degasperi, L. Duca +9 more
2024Journal of Hepatology1 citations
Semantic Scholar
WED-391 Long-term virological and clinical outcomes of patients with HDV-related compensated cirrhosis treated with bulevirtide monotherapy for up to 120 weeks: a retrospective multicenter european study (save-d)
E. Degasperi, M. P. Anolli, M. Jachs, T. Reiberger +50 more
2024Journal of Hepatology1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. P. Anolli×20
Invite
M. P. Anolli — researcher profile on SciRah
M. Brunetto×20
Invite
M. Brunetto — researcher profile on SciRah
P. Lampertico×18
Invite
P. Lampertico — researcher profile on SciRah
A. Loglio×17
Invite
A. Loglio — researcher profile on SciRah

×16

Invite

F. Facchetti — researcher profile on SciRah

D. Sambarino×16

Invite

D. Sambarino — researcher profile on SciRah

R. Perbellini×13

Invite

R. Perbellini — researcher profile on SciRah

T. Santantonio×12

Invite

T. Santantonio — researcher profile on SciRah

Invite

M. Borghi — researcher profile on SciRah

A. Pellicelli×11

Invite

A. Pellicelli — researcher profile on SciRah

Invite

F. Pileri — researcher profile on SciRah

Invite

M. Maracci — researcher profile on SciRah